Study of ErbiumYAG Laser with Vaginal Estriol Cream for Treating Genitourinary Syndrome in Postmenopausal Women Aged 45 to 70
Led by University of Nove de Julho · Updated on 2026-04-23
60
Participants Needed
1
Research Sites
7 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying Genitourinary Syndrome of Menopause GSM in postmenopausal women, a condition caused by chronic low estrogen levels that affect the urogenital tract and increase the risk of infections due to higher vaginal pH. This randomized, double-blind clinical trial aims to compare the effects of combining ErbiumYAG ErYAG laser therapy with low-dose vaginal estriol cream against estriol therapy alone in improving symptoms and vaginal health in women aged 45 to 70 years with moderate GSM symptoms.
Participants will all use low-dose vaginal estriol cream for 14 days daily, then twice weekly until completing three laser sessions spaced four weeks apart. One group will receive a sham laser treatment with minimal energy that does not affect tissues but maintains blinding, while the other group will receive an active ErYAG laser treatment targeting the vaginal canal and external vulvar areas with specific energy settings. The laser device used is a 2940 nm wavelength Smooth XS Dynamics Dualis.
During the study, assessments will be done at baseline, 30 days after each laser session, and four months after the third session. Researchers will measure vaginal health using the Vaginal Health Index, evaluate symptoms via a visual analog scale, analyze vaginal microbiota with gene sequencing, and collect quality of life and sexual health questionnaire data. Safety and statistical analyses will be conducted to compare the effects between groups over time.
CONDITIONS
Brief Title
Er:YAG Laser Combined With Vaginal Estriol for Genitourinary Syndrome of Menopause
Research Team
S
Stella Zamuner
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Moderate symptoms of GSM (vaginal dryness, burning, pain during sex, persistent discharge) with a score of 4 or higher on a 0-10 scale
Vaginal pH of 5.0 or higher at baseline
No hormone therapy (vaginal or systemic) in the last 6 months
No use of vaginal moisturizers in the last 30 days
Ability and willingness to give written informed consent and follow study procedures
You will not qualify if you...
Vaginal or vulvar energy-based treatments (e.g., laser, radiofrequency) in the last 6 months
Abnormal cervical cytology (ASCUS, LSIL, HSIL) in the last 6 months
Systemic corticosteroid therapy in the last 90 days
Body mass index (BMI) of 35 kg/m² or higher
Abnormal uterine bleeding in the last 30 days
Vaginal surgery in the last 180 days or grade II or higher uterine prolapse
History of malignant neoplasms or vaginal radiotherapy
Severe liver or kidney disease, autoimmune disease, or severe psychiatric disorder
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - Approximately 12 to 14 weeks
Participants receive low-dose vaginal estriol cream daily for 14 days followed by twice weekly applications while undergoing three laser sessions spaced about 4 weeks apart. The laser sessions include either active Er:YAG laser treatment or sham laser treatment depending on group assignment.
Participants are assessed four months after the third laser session to evaluate the long-term effects of the treatment on vaginal health and symptoms.
1 follow-up visit (in-person)
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Evaluating a New Hormone-Free Gel for Managing Menopause-Related Genitourinary Symptoms in Women Aged 40 to 70
Combining Topical Hyaluronic Acid and High-Concentration Vaginal Oxygen Therapy to Improve Symptoms of Genitourinary Syndrome of Menopause in Postmenopausal Women Including Breast Cancer Survivors
Studying Genitourinary Syndrome of Menopause in Women with Breast Cancer Receiving Endocrine Therapy or Chemotherapy Compared to Healthy Women
Comparing Telerehabilitation and In-Person Physical Therapy to Improve Sexual Function and Reduce Pain in Menopausal Women with Dyspareunia
Study of ErbiumYAG Laser with Vaginal Estriol Cream for Treating Genitourinary Syndrome in Postmenopausal Women Aged 45 to 70
Comparing Silicone Gel and Estrogen Vaginal Cream to Treat Genitourinary Syndrome of Menopause
Study of Vaginal Laser Therapy Using Advanced Imaging to Treat Menopause-Related Symptoms
Laser Treatment for Genitourinary Syndrome in Breast Cancer Survivors Undergoing Endocrine Therapy
A Randomized, Blinded, Placebo-Controlled Study Using Vaginal CO2 Laser
Study of a Non-Hormonal Gel for Treating Vulvovaginal Skin Conditions in Adult Women
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Effects of Erbium:YAG laser combined with vaginal estriol therapy in postmenopausal women with Genitourinary Syndrome of Menopause: protocol for a randomised, double-blind, controlled trial.
Mônica Cristina da Costa Drago Souza, Zsuzsanna I K de Jármy-Di Bella, Ana Maria H M Bianchi-Ferraro...